These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 1453197)

  • 1. Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials Group.
    Coates A; Gebski V; Signorini D; Murray P; McNeil D; Byrne M; Forbes JF
    J Clin Oncol; 1992 Dec; 10(12):1833-8. PubMed ID: 1453197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality-of-life scores predict outcome in metastatic but not early breast cancer. International Breast Cancer Study Group.
    Coates AS; Hürny C; Peterson HF; Bernhard J; Castiglione-Gertsch M; Gelber RD; Goldhirsch A
    J Clin Oncol; 2000 Nov; 18(22):3768-74. PubMed ID: 11078489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-reported health-related quality of life is an independent predictor of chemotherapy treatment benefit and toxicity in women with advanced breast cancer.
    Lee CK; Stockler MR; Coates AS; Gebski V; Lord SJ; Simes RJ;
    Br J Cancer; 2010 Apr; 102(9):1341-7. PubMed ID: 20389302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of quality of life scores in a trial of chemotherapy with or without interferon in patients with metastatic malignant melanoma.
    Coates A; Thomson D; McLeod GR; Hersey P; Gill PG; Olver IN; Kefford R; Lowenthal RM; Beadle G; Walpole E
    Eur J Cancer; 1993; 29A(12):1731-4. PubMed ID: 8398303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of quality-of-life scores: preliminary results of an analysis of patients with breast cancer.
    Shimozuma K; Sonoo H; Ichihara K; Tanaka K
    Surg Today; 2000; 30(3):255-61. PubMed ID: 10752779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and interpretation of clinical and quality of life prognostic factors for survival and response to treatment in first-line chemotherapy in advanced breast cancer.
    Kramer JA; Curran D; Piccart M; de Haes JC; Bruning P; Klijn J; Van Hoorebeeck I; Paridaens R
    Eur J Cancer; 2000 Aug; 36(12):1498-506. PubMed ID: 10930797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. When do patient reported quality of life indicators become prognostic in breast cancer?
    Lee CK; Hudson M; Simes J; Ribi K; Bernhard J; Coates AS
    Health Qual Life Outcomes; 2018 Jan; 16(1):13. PubMed ID: 29329582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies.
    Coates A; Gebski V; Bishop JF; Jeal PN; Woods RL; Snyder R; Tattersall MH; Byrne M; Harvey V; Gill G
    N Engl J Med; 1987 Dec; 317(24):1490-5. PubMed ID: 3683485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective assessment of quality of life after endoscopic intubation and laser therapy for malignant dysphagia.
    Loizou LA; Rampton D; Atkinson M; Robertson C; Bown SG
    Cancer; 1992 Jul; 70(2):386-91. PubMed ID: 1377593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life assessment in patients receiving adjuvant therapy for breast cancer: the IBCSG approach. The International Breast Cancer Study Group.
    Bernhard J; Hürny C; Coates AS; Peterson HF; Castiglione-Gertsch M; Gelber RD; Goldhirsch A; Senn HJ; Rudenstam CM
    Ann Oncol; 1997 Sep; 8(9):825-35. PubMed ID: 9358933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining clinical benefit in postmenopausal patients with breast cancer under second-line endocrine treatment: does quality of life matter?
    Bernhard J; Thürlimann B; Schmitz SF; Castiglione-Gertsch M; Cavalli F; Morant R; Fey MF; Bonnefoi H; Goldhirsch A; Hürny C
    J Clin Oncol; 1999 Jun; 17(6):1672-9. PubMed ID: 10561203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic association of health-related quality of life scores with survival in breast cancer.
    Gupta D; Granick J; Grutsch JF; Lis CG
    Support Care Cancer; 2007 Apr; 15(4):387-93. PubMed ID: 17093913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life in oncology practice: prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy.
    Coates A; Porzsolt F; Osoba D
    Eur J Cancer; 1997 Jun; 33(7):1025-30. PubMed ID: 9376182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic value of quality of life scores during treatment for oesophageal cancer.
    Blazeby JM; Brookes ST; Alderson D
    Gut; 2001 Aug; 49(2):227-30. PubMed ID: 11454799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Quality of life and mortality of patients in intensive care. Indices of quality of life].
    Ortiz D; Galguera F; Jam MR; Vilar S; Castella X; Artigas A
    Enferm Intensiva; 1998; 9(4):141-50. PubMed ID: 10409976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93.
    ; Rudenstam CM; Zahrieh D; Forbes JF; Crivellari D; Holmberg SB; Rey P; Dent D; Campbell I; Bernhard J; Price KN; Castiglione-Gertsch M; Goldhirsch A; Gelber RD; Coates AS
    J Clin Oncol; 2006 Jan; 24(3):337-44. PubMed ID: 16344321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicollinearity in prognostic factor analyses using the EORTC QLQ-C30: identification and impact on model selection.
    Van Steen K; Curran D; Kramer J; Molenberghs G; Van Vreckem A; Bottomley A; Sylvester R
    Stat Med; 2002 Dec; 21(24):3865-84. PubMed ID: 12483772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant chemoradiotherapy for patients with nonmetastatic breast carcinoma: side effects, quality of life, and organization.
    Macquart-Moulin G; Viens P; Genre D; Bouscary ML; Resbeut M; Gravis G; Camerlo J; Maraninchi D; Moatti JP
    Cancer; 1999 May; 85(10):2190-9. PubMed ID: 10326697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timing of baseline quality of life assessment in an international adjuvant breast cancer trial: its effect on patient self-estimation. The International Breast Cancer Study Group.
    Hürny C; Bernhard J; Coates A; Castiglione M; Peterson HF; Gelber RD; Rudenstam CM; Goldhirsch A; Senn HJ
    Ann Oncol; 1994 Jan; 5(1):65-74. PubMed ID: 8172795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.